Neoadjuvant chemotherapy and chemoradiotherapy in locally advanced stages IIIA and IIIB of non-small cell lung cancer (treatment protocol of Essen University Hospital);Neoadjuvante Chemotherapie und Chemoradiotherapie in den lokal-fortgeschrittenen Stadien IIIA und IIIB des nichtkleinzelligen Bronchialkarzinoms (Essener Konzept)

Praxis

Volumn 86, Issue 42, 1997, Pages 1647-1653

  Eberhardt, W ^a,b  

^a Westdeutschen Tumorzentrum Essen   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

chemoradiotherapy; chemotherapy; induction therapy; non small cell lung cancer; preoperative; stage III

Indexed keywords

CARBOPLATIN; CISPLATIN; ETOPOSIDE; FLUOROURACIL; VINBLASTINE;

ADJUVANT CHEMOTHERAPY; CANCER CHEMOTHERAPY; CANCER REGRESSION; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; LUNG CANCER; RANDOMIZED CONTROLLED TRIAL; SHORT SURVEY; SMALL CELL CARCINOMA;

CARCINOMA, NON-SMALL-CELL LUNG; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; HUMANS; LUNG NEOPLASMS; NEOPLASM STAGING; PNEUMONECTOMY; PROGNOSIS; PROSPECTIVE STUDIES; RADIOTHERAPY, ADJUVANT; SURVIVAL RATE;

EID: 0030758916     PISSN: 16618157     EISSN: 16618165     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (28)

1. Parker S.L., Tong T., Bolden S., et al.: Cancer statistics, 1997 CA: 47: 5-27, 1997.
2. Mountain C.F.: A new international staging system for lung cancer. Chest: 89 (4 Suppl.): 225-233, 1986.
3. Ginsberg R.J., Kris M.G., Armstrong J.G.: Cancer of the Lung. Section 1: Non-Small Cell Lung Cancer, in DeVita VT Jr, Hellmann S, Rosenberg SA (eds): Cancer: Principles and Practice of Oncology. 4. ed. Philadelphia, PA, Lippincott, pp 673-723, 1993.
4. Perez C.A., Pajak T.F., Rubin P., et al.: Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy. Cancer: 59: 1874-1881, 1987.
5. Hazuka M.B., Bunn P.A.: Controversies in the nonsurgical treatment of stage III non-small cell lung cancer. Am Rev Respir Dis: 145:967-977, 1992.
6. Feld R., Rubinstein L., Thomas P., et al.: Adjuvant chemotherapy with cyclophosphamide, doxorubicin, and cisplatin in patients with completely resected stage I non-small cell lung cancer JNCI; 85: 299-306, 1993.
7. Shepherd F.A.: Induction Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer. Ann Thorac Surg; 55: 1985, 1993.
8. Johnson D.H., Turrisi A., Pass H.J.: Combined Modality Treatment for Locally Advanced Non-Small Cell Lung Cancer, in Lung Cancer: Principles and Practice, eds HJ Pass, JB Mitchell, DH Johnson, AT Turrisi. Lippincott Raven Publishers. Philadelphia, pp 863-873, 1996.
9. Thames H.D., Bentzen S.M., Turesson I., et al.: Time-dose factors in radiotherapy: a review of the human data. Radiother.Oncol.; 19: 219-235, 1990.
10. Vokes E.E., Weichselbaum R.R.: Concomitant Chemoradiotherapy: Rationale and Clinical Experience in Patients with Solid Tumors. J Clin Oncol: 8: 911-934, 1990.
11. Turrisi A. T. III, Glover D.J., Mason B.A.: A preliminary report: Concurrent twice-daily radiotherapy plus platinum-etoposide chemotherapy for limited small cell lung cancer. Int J Radiat Oncol Biol Phys; 15:183-187, 1988.
12. Shaw E.G., McGinnis W.L., Jett J.R., et al.: Pilot Study of Accelerated Hyperfractionated Thoracic Radiation Therapy Plus Concomittant Etoposide and Cisplatin Chemotherapy in Patients With Unresectahle Stage III Non-Small Cell carcinoma of the Lung. J Natl Cancer Inst: 85:321-323, 1993.
13. Kaplan E.L., Meier P.: Nonparametric Estimation from Incomplete Observations. JASA; 53: 457-481, 1958.
14. Green M.R., Cox J.D., Ardizzoni A., et al.: Endpoints for multimodal clinical trials in stage III non-small cell lung cancer: A consensus report. Lung Cancer; 11: Suppl. 3; 11-13, 1994.
15. Kawahara M., Furuse K., Kanmimori T., et al.: Risk of Second Primary Tumor in > 2 Year Disease-Free Survivors of Small Cell Lung Cancer in Japan. Proc Am Soc Clin Oncol 14:353. abst 1070, 1995.
16. Quoix E., Moro D., Jacoulet P., et al.: Long-term Survivors in Non-Resected Non-Small Cell Lung Cancer Patients: A French Data Base. Proc Am Soc Clin Oncol, 14:368, abst 1130, 1995.
17. Dillman R.O., Seagren S.L., Propert K., et al.: A Randomized Trial of Induction Chemotherapy plus high-dose Radiation versus Radiation alone in Stage III Non-Small Cell Lung Cancer. N Engl JMed; 323:940-945,1990.
18. Dillman R.O., Seagren S.L., Herndou J., et al.: Randomized Trial of Induction Chemotherapy plus Radiation Therapy vs. RT alone in Stage III Non-Small Cell Lung Cancer: Five Year Followup of CALGB 84-33. Proc Am Soc Clin Oncol; 12: 329.Abst 1092, 1993.
19. Le Chevalier T., Arriagada R., Tarayre M., et al.: Significant Effect of Adjuvant Chemotherapy on Survival in Locally Advanced Non-Small Cell Lung carcinoma. JNCI; 84:58-60,1992.
20. van Raemdonck D.E., Schneider A., Ginsberg R.J.: Surgical treatment for higher stage non-small cell lung cancer. Ann Thorac Surg; 54: 999-1013, 1992.
21. Fowler W.C., Langer C.J., Curran W.J., et al.: Postoperative complications after combined neoadjuvant treatment of lung cancer. Ann Thorac Surg; 55: 986-989, 1993.
22. Weiden P.L., Piantadosi S., for the Lung Cancer Study Group: Preoperative chemotherapy (cisplatin and fluorouracil) and radiation therapy in stage III non-small cell lung cancer: A phase II study of the Lung Cancer Study Group. J Natl Cancer Inst; 83: 266-273, 1991.
23. Strauss G.M., Herndon J.E., Sherman D.D., et al: Neoadjuvant Chemotherapy and Radiotherapy Followed by Surgery in Stage IIIA Non-Small Cell Carcinoma of the Lung: Report of a Cancer and Leukemia Group B Phase II Study. J Clin Oncol; 10: 1237-1244, 1992.
24. Patazzi M., Cutaldo I., Gramaglia A., et al.: Preoperative Concomittant Cisplatin and Radiotherapy in Stage III Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys; 27: 621-625 1993.
25. Deutsch M., Crawford J., Leopold K., et al.: Phase II Study of Neoadjuvant Chemotherapy and Radiation Therapy with Thoracotomy in the Treatment of Clinically Staged IIIA Non-Small Cell Lung Cancer. Cancer; 74: 1243-1252, 1994.
26. Albain K.S., Rusch V.W., Crowley J.J., et al.: Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small cell lung cancer: mature results of Southwest Oncology Group phase II study 8805. J.Clin.Oncol.; 13: 1880-1892 1995.
27. Favaretto A., Paccagnella A., Tomio L., et al.: Preoperative Chemoradiotherapy in Non-Small Cell Lung Cancer Stage III Patients. Feasibility. Toxicity and Long-term Results of a Phase II Study. Eur J Cancer; 12: 2064-2069, 1996.
28. Choi N.C., Carey R. W., Daly W., el al.: Polential Impact on Survival of Improved Tumor Downstaging and Resection Rate by Preoperative Twice-Daily Radiation and Concurrent Chemotherapy in Stage IIIA Non-Small-Cell Lung Cancer. J.Clin.Oncol.; 15: 712-722, 1997.